Age-related macular degeneration (AMD) encompasses a wide spectrum of retinal changes within the central fundus which can result in a varying amount of functional impairment,1 often significantly impacting on the affected individual’s quality of life.2 In the early stages of the disease, and more commonly in the intermediate stages, sufferers can complain of a variety of difficulties with everyday tasks such as reading and face recognition.
A wide variety of functional measures of visual performance have been shown to be significantly reduced at this stage of the disease.3,4 As there is currently no medical intervention for individuals presenting with such features and symptoms of non-exudative AMD, and with a large increase in the prevalence of the number of individuals presenting with the disease over the next number of years,5 the option of non-medical interventions in the management of such patients is important.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here